Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
- PMID: 7985312
- DOI: 10.1016/s0090-4295(94)80167-3
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
Abstract
Objectives: Tiny papillary tumors and flat urothelial lesions such as dysplasia or carcinoma in situ can easily be missed during routine cystoscopy. Various methods for in vivo detection of fluorescing agents (preferentially localized in malignant tissue) have been developed. Most of them are based on systemically administered synthetic porphyrin compounds and require sensitive detection devices and image processing units for fluorescence visualization. The usefulness of intracellularly accumulated endogenous protoporphyrin IX (PPIX), induced by 5-aminolevulinic acid (ALA), for diagnosis of early bladder cancer and the correlation with cystoscopic, microscopic, and fluorescence findings was investigated.
Methods: ALA was instilled intravesically in 68 patients, followed by fluorescence cystoscopy with violet light from a krypton ion laser that produced fluorescence excitation. There were 299 biopsies obtained from fluorescing and nonfluorescing areas of the bladder.
Results: ALA-induced fluorescence could be easily observed with the naked eye during cystoscopy under violet light illumination. All tumor lesions were sharply marked with brightly shining red fluorescence. Correlation of fluorescence and microscopic findings gave a sensitivity of 100% and a specificity of 68.5%. There were 26 malignant or precancerous lesions that were missed during routine cystoscopy but were detected only by ALA-induced fluorescence.
Conclusions: Labeling of urothelial lesions by PPIX fluorescence induced by intravesically instilled ALA seems to be a promising diagnostic procedure for malignant lesions that are difficult to visualize with standard cystoscopy.
Similar articles
-
Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias.Urol Int. 1995;55(4):190-6. doi: 10.1159/000282784. Urol Int. 1995. PMID: 8588264
-
Diagnostic efficacy of fluorescence cystoscopy for detection of urothelial neoplasms.J Endourol. 2001 Sep;15(7):753-9. doi: 10.1089/08927790152596370. J Endourol. 2001. PMID: 11697410 Clinical Trial.
-
Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.Urology. 1994 Nov;44(5):676-81. doi: 10.1016/s0090-4295(94)80203-3. Urology. 1994. PMID: 7974943
-
["... The better to see you with"--phothodynamic diagnostic in superficial bladder cancer].Praxis (Bern 1994). 2007 Oct 17;96(42):1631-7. doi: 10.1024/1661-8157.96.42.1631. Praxis (Bern 1994). 2007. PMID: 17974123 Review. German.
-
Improving the management of bladder cancer with fluorescence cystoscopy.J Environ Pathol Toxicol Oncol. 2007;26(2):143-7. doi: 10.1615/jenvironpatholtoxicoloncol.v26.i2.90. J Environ Pathol Toxicol Oncol. 2007. PMID: 17725540 Review.
Cited by
-
Efficacy of 5-aminolevulinic acid-mediated photodynamic therapy using light-emitting diodes in human colon cancer cells.Oncol Rep. 2013 Mar;29(3):911-6. doi: 10.3892/or.2013.2220. Epub 2013 Jan 3. Oncol Rep. 2013. PMID: 23291627 Free PMC article.
-
Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.Int J Nanomedicine. 2012;7:2497-512. doi: 10.2147/IJN.S29582. Epub 2012 May 17. Int J Nanomedicine. 2012. PMID: 22679363 Free PMC article.
-
Enhanced Endoscopy in Bladder Cancer.Curr Urol Rep. 2018 Aug 17;19(10):84. doi: 10.1007/s11934-018-0833-9. Curr Urol Rep. 2018. PMID: 30116985 Review.
-
Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.Br J Cancer. 1999 Apr;80(1-2):185-93. doi: 10.1038/sj.bjc.6690338. Br J Cancer. 1999. PMID: 10389995 Free PMC article. Clinical Trial.
-
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper.J Porphyr Phthalocyanines. 2020 Nov-Dec;24(11n12):1320-1360. doi: 10.1142/s1088424620300098. J Porphyr Phthalocyanines. 2020. PMID: 37425217 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical